K-numberK251951
Device nameSingle-Use Video Flexible Ureterorenoscope (RP-U-C03R9, RP-U-C03R3, RP-U-C03S9, RP-U-C03S3); Endoscopic Video Image Processor (RP-IPD-V2000EF); Endoscopic Video Image Processor (RP-IPD-V1000F)
ApplicantGuangzhou Red Pine Medical Instrument Co., Ltd.
Product codeFGB
Device classClass II
Decision dateDec 16, 2025
DecisionSubstantially Equivalent
Regulation876.1500
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The device is a single-use video flexible ureterorenoscope system used for endoscopy and endoscopic surgery within the urinary tract, ureter, and kidney. It consists of four ureterorenoscope models and two endoscopic video image processors that work together to provide visualization and surgical capability in urological procedures.

Technological characteristics

The proposed ureterorenoscopes have a smaller outer diameter (2.50 mm vs 2.85–2.9 mm), smaller maximum insertion width (2.75 mm vs 3.15–3.2 mm), and improved bending angle (up/down 285° vs 275°) compared to the predicate. The image processors differ in dimension, weight, video signal outputs (added DVI and SDI interfaces), and zoom range, but maintain the same white balance and brightness adjustment functionality.

Test standards cited

ISO 8600 (endoscope testing), ISO 10993-1 (biocompatibility), ISO 11135:2014 (sterilization), ASTM F1980-21 (shelf life), ASTM F1886/F1886M-16, ASTM D4169-23, ASTM F1929-23, ASTM F88/F88-23 (packaging), IEC 60601-1:2005 and amendments, IEC 60601-2-18:2009, IEC 60601-1-2:2014 (electrical safety and EMC).

Substantial equivalence argument

The proposed device is substantially equivalent to predicate K221158 because it performs the same intended function with identical principles of operation and target anatomy. Non-clinical performance testing demonstrates equivalent optical and mechanical performance; dimensional and design differences (smaller diameter, enhanced bending capability, additional video outputs) represent improvements or clarifications that do not raise new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →